• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的家族性高胆固醇血症。低密度脂蛋白受体基因突变导致受体阴性表型的鉴定。

Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.

作者信息

Sun X M, Patel D D, Webb J C, Knight B L, Fan L M, Cai H J, Soutar A K

机构信息

MRC Lipoprotein Team, Hammersmith Hospital, London, UK.

出版信息

Arterioscler Thromb. 1994 Jan;14(1):85-94. doi: 10.1161/01.atv.14.1.85.

DOI:10.1161/01.atv.14.1.85
PMID:7903864
Abstract

Familial hypercholesterolemia (FH), caused by many different mutations in the low-density lipoprotein (LDL)-receptor gene, invariably leads to severe premature coronary heart disease (CHD) in homozygous individuals. Heterozygous FH patients are less severely affected but are still at increased risk of CHD in most populations. Although FH homozygotes in China are affected similarly to those elsewhere, heterozygotes are not detected in the general population and obligate heterozygotes are often not hypercholesterolemic by Western standards. Mutations in the LDL-receptor genes of 10 homozygous FH patients from the Jiang-su province of China and their heterozygous parents were analyzed. These include one large and two minor deletions and eight point mutations: four are predicted to introduce a premature stop codon, five to result in a single amino acid substitution or deletion, and one to produce a protein with an abnormal cytoplasmic tail. Expression of the mutant LDL-receptor cDNAs in vitro confirmed that these mutations impaired LDL-receptor function and that several would cause a receptor-negative phenotype. Thus, the lack of clinical expression in obligate FH heterozygotes is not due to unusually "mild" mutations in the LDL-receptor gene, and other genetic or environmental factors must therefore be important in determining phenotypic expression.

摘要

家族性高胆固醇血症(FH)由低密度脂蛋白(LDL)受体基因的多种不同突变引起,在纯合个体中总会导致严重的早发性冠心病(CHD)。杂合子FH患者受影响程度较轻,但在大多数人群中患冠心病的风险仍然增加。尽管中国的FH纯合子与其他地方的患者受影响情况相似,但在普通人群中未检测到杂合子,而且按照西方标准,必然的杂合子通常没有高胆固醇血症。对来自中国江苏省的10名FH纯合子患者及其杂合子父母的LDL受体基因中的突变进行了分析。这些突变包括1个大片段缺失、2个小片段缺失和8个点突变:4个预计会引入提前终止密码子,5个会导致单个氨基酸替代或缺失,1个会产生具有异常细胞质尾的蛋白质。突变型LDL受体cDNA的体外表达证实这些突变损害了LDL受体功能,其中一些会导致受体阴性表型。因此,必然的FH杂合子缺乏临床表型并非由于LDL受体基因存在异常“温和”的突变,所以其他遗传或环境因素在决定表型表达方面必定很重要。

相似文献

1
Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.中国的家族性高胆固醇血症。低密度脂蛋白受体基因突变导致受体阴性表型的鉴定。
Arterioscler Thromb. 1994 Jan;14(1):85-94. doi: 10.1161/01.atv.14.1.85.
2
A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.一名家族性高胆固醇血症的中国纯合子:低密度脂蛋白受体基因中一个新的C263R突变的鉴定。
J Hum Genet. 2001;46(3):152-4. doi: 10.1007/s100380170104.
3
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
4
Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom.纯合子家族性高胆固醇血症患者低密度脂蛋白(LDL)受体基因突变的特征,以及这些突变在英国FH患者中的频率。
J Lipid Res. 1996 Feb;37(2):368-81.
5
[Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].[从一名家族性高胆固醇血症患者中鉴定低密度脂蛋白受体基因位点的新型突变]
Sheng Li Xue Bao. 2004 Oct 25;56(5):566-72.
6
Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia.丹麦低密度脂蛋白受体基因突变谱:对杂合子家族性高胆固醇血症分子诊断策略的影响
Atherosclerosis. 1999 Oct;146(2):337-44. doi: 10.1016/s0021-9150(99)00158-6.
7
FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.FH阿非利卡人-3低密度脂蛋白受体突变导致低密度脂蛋白受体缺陷,并引起轻度家族性高胆固醇血症。
Arterioscler Thromb Vasc Biol. 1995 Jun;15(6):765-72. doi: 10.1161/01.atv.15.6.765.
8
Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada.杂合子家族性高胆固醇血症的表型变异:中国与加拿大 LDL 受体基因具有相同或相似突变的中国患者比较。
Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):309-15. doi: 10.1161/01.atv.18.2.309.
9
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.4名纯合子家族性高胆固醇血症患者的表型变异性,这些患者为低密度脂蛋白受体(LDLR)突变的复合杂合子。
J Clin Lipidol. 2016 Jul-Aug;10(4):944-952.e1. doi: 10.1016/j.jacl.2016.04.005. Epub 2016 Apr 21.
10
[Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].[中国一个家族性高胆固醇血症家系中低密度脂蛋白受体基因新剪接突变的鉴定]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Feb;21(1):14-8.

引用本文的文献

1
Impact of LDLR polymorphisms on lipid levels and atorvastatin's efficacy in a northern Chinese adult Han cohort with dyslipidemia.低密度脂蛋白受体基因多态性对中国北方成年汉族血脂异常人群血脂水平及阿托伐他汀疗效的影响
Lipids Health Dis. 2024 Apr 14;23(1):106. doi: 10.1186/s12944-024-02101-4.
2
Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.家族性高胆固醇血症中鉴定到影响低密度脂蛋白代谢的新型 LDLR 变体。
Mol Biol Rep. 2024 Jan 18;51(1):153. doi: 10.1007/s11033-023-09169-8.
3
Development of New Genome Editing Tools for the Treatment of Hyperlipidemia.
新型基因组编辑工具治疗高血脂症的研究进展
Cells. 2023 Oct 16;12(20):2466. doi: 10.3390/cells12202466.
4
Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis.基因组编辑技术在CAD研究与治疗中的应用,重点关注动脉粥样硬化
Int J Mol Sci. 2023 Sep 13;24(18):14057. doi: 10.3390/ijms241814057.
5
Identification of an variant in a Chinese familial hypercholesterolemia and its relation to ROS/NLRP3-Mediated pyroptosis in hepatic cells.中国家族性高胆固醇血症中一种变异体的鉴定及其与肝细胞中ROS/NLRP3介导的细胞焦亡的关系。
J Geriatr Cardiol. 2023 May 28;20(5):341-349. doi: 10.26599/1671-5411.2023.05.003.
6
Candidate SNP Markers Significantly Altering the Affinity of TATA-Binding Protein for the Promoters of Human Hub Genes for Atherogenesis, Atherosclerosis and Atheroprotection.候选单核苷酸多态性标记物显著改变 TATA 结合蛋白与人类动脉粥样硬化、动脉粥样硬化和动脉保护关键基因启动子的亲和力。
Int J Mol Sci. 2023 May 19;24(10):9010. doi: 10.3390/ijms24109010.
7
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases.CRISPR/Cas9基因编辑作为遗传性疾病治疗策略的潜力
Front Cell Dev Biol. 2021 Dec 15;9:699597. doi: 10.3389/fcell.2021.699597. eCollection 2021.
8
Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.中国 208 例家族性高胆固醇血症患者的靶向基因分析。
J Atheroscler Thromb. 2020 Dec 1;27(12):1288-1298. doi: 10.5551/jat.54593. Epub 2020 Aug 6.
9
Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems.中国家族性高胆固醇血症的现状:建立患者FH登记系统的必要性。
Front Physiol. 2019 Mar 20;10:280. doi: 10.3389/fphys.2019.00280. eCollection 2019.
10
Novel compound heterozygous mutations in low density lipoprotein receptor gene causes a severe phenotype in a Chinese hypercholesterolemia family.低密度脂蛋白受体基因中的新型复合杂合突变在中国一个高胆固醇血症家族中导致严重表型。
Exp Ther Med. 2018 Aug;16(2):901-907. doi: 10.3892/etm.2018.6205. Epub 2018 May 23.